In light of emerging therapeutic drug‐repurposing strategies targeting ATPase‐related encephalopathies,41 it will be crucial to further understand downstream mechanisms and the role of LoF and dominant‐negative variants in these disorders. Here, DNAH8 is linked to Encephalopathy.